Public Release:  Hispanic stroke patients less likely to receive clot-busting drugs in

Abstract TMP24 (Room Hall G)

American Heart Association

Hispanic stroke patients admitted to hospitals in the border states of California, Arizona, New Mexico and Texas were less likely than non-Hispanics in the same border states to receive clot-busting drugs and more likely to die, according to research presented at the American Stroke Association's International Stroke Conference 2014.

Researchers analyzed stroke care for Hispanic and non-Hispanic patients according to demographics and clinical characteristics in states bordering Mexico and states not on the Mexican border. They found:

  • Of the nearly 35,000 Hispanic stroke patients, 21,130 were admitted in border states and 13,774 in non-border states.
  • Only 4.8 percent of Hispanic patients in border state hospitals received clot-busting drugs compared to 5.7 percent of non-Hispanic patients in border state hospitals.
  • Hispanic stroke patients were 30 percent more likely than non-Hispanics to die in border state hospitals.
  • There was no notable difference in death rates between Hispanic and non-Hispanic stroke patients in non-border state hospitals. Researchers say more study is needed to determine why clot-busters are underutilized in Hispanics admitted in border states but not in other states.


Note: Actual presentation is 6:10 p.m. PT Thursday, Feb. 13, 201

Follow news from the International Stroke Conference 2014 via Twitter: @HeartNews #ISC14.

Statements and conclusions of study authors that are presented at American Stroke Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at

B-roll, animation or images related to these tips are on the right column of this link

NOTE ALL TIMES ARE PACIFIC (PT). ALL TIPS ARE EMBARGOED UNTIL THE TIME OF PRESENTATION OR 3 P.M. PT/6 P.M. ET EACH DAY, WHICHEVER COMES FIRST. For more information Feb. 12-14, call the ASA News Media Staff Office at the San Diego Convention Center at (619) 525-6204. Before or after these dates, call the Communications Office in Dallas at (214) 706-1173. For public inquiries, call (800) AHA-USA1 (242-8721).

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.